Development of a Risk Prediction Model for Bone Metastasis in Lung Adenocarcinoma With a T1 Primary Tumor Based on Intratumoral and Peritumoral Radiomics
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.71996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 28.05.2026. Verfasst von Ting Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Purpose
Bone metastasis significantly affects the prognosis of lung adenocarcinoma (LUAD) patients. This study aims to construct and validate a risk prediction model for bone metastasis in LUAD with a T1 primary tumor based on intratumoral and peritumoral radiomics features. Materials and Methods A total of 392 patients pathologically diagnosed with LUAD and a T1 primary tumor from two medical centers were retrospectively included (training cohort: n = 217, internal validation cohort: n = 93, external validation cohort: n = 82). Univariate and multivariate analyses identified independent risk factors for the clinicoradiologic model. Radiomics features were extracted from the gross tumor volume (GTV) and peritumoral tumor volume (PTV) in the training cohort CT images to establish intratumoral and peritumoral radiomics models. The optimal radiomics model was combined with clinicoradiologic features to develop a nomogram. Model performance was assessed using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA).
Results
Among 392 LUAD patients with a T1 primary tumor, 147 had bone metastasis. The clinicoradiologic model incorporated three predictors: lymph node enlargement, pleural effusion, and carcinoembryonic antigen (CEA) levels. The PTV (−3 to 3 mm) radiomics model showed high discrimination performance, with an AUC of 0.810 (95% CI: 0.712–0.908) in the external validation cohort. The nomogram model demonstrated the highest discrimination performance, with an AUC of 0.884 (95% CI: 0.715–0.946), and showed acceptable calibration.
Conclusion
In this retrospective two‐center cohort of patients with LUAD and a T1 primary tumor, the combined clinicoradiologic‐radiomics nomogram showed potential for stratifying the risk of synchronous bone metastasis at baseline evaluation. Further validation in larger and more representative cohorts is warranted before broader clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- The Second School of Clinical Medicine, Wuhan University, Wuhan, China.
- Department of Radiology, Wuhan Central Hospital, Wuhan, China.
Förderung
- Zhongnan Hospital of Wuhan University
Zitieren
APA
Li, T., Zheng, H., Guo, Y., Zhang, K., & Liao, M. (2026). Development of a Risk Prediction Model for Bone Metastasis in Lung Adenocarcinoma With a T1 Primary Tumor Based on Intratumoral and Peritumoral Radiomics. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71996
Vancouver
Li T, Zheng H, Guo Y, Zhang K, Liao M. Development of a Risk Prediction Model for Bone Metastasis in Lung Adenocarcinoma With a T1 Primary Tumor Based on Intratumoral and Peritumoral Radiomics. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71996
BibTeX
@article{Li2026,
author = {Li, Ting and Zheng, Hui and Guo, Yang and Zhang, Kemeng and Liao, Meiyan},
title = {Development of a Risk Prediction Model for Bone Metastasis in Lung Adenocarcinoma With a T1 Primary Tumor Based on Intratumoral and Peritumoral Radiomics},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.71996}
}
EUVIMED